Brower Piven Files Class Action Suit Against Celera Corporation (NasdaqGS: CRA)

$8.00 per share in cash ("Tender Offer"). Celera is a healthcare business focusing on the integration of genetic testing into routine clinical care through a combination of products and services incorporating proprietary discoveries. The complaint states...